@twmarkc

A Pathologist & Cytopathologist in Taiwan. Interests in Cancer biology, Cyto, Hema, Bioinformatics. Ex President of Taiwan Society Clinical Cytology.

 Taiwan
researchgate.net/profile/Chienchin_Chen/contributions
Joined September 2013
  • Tweets4.6K
  • Following347
  • Followers1.2K
433Media
Mark CC Chen, M.D. FIAC retweeted
Cioly Rivero C.
@CiolyRiveroCOct 1
#CytoJ #ECCyto2026
Cytopathology@CytopathologyJOct 1
4
6
324
Mark CC Chen, M.D. FIAC retweeted
Cioly Rivero C.
@CiolyRiveroCSep 28
Join the #SLAC companion meeting #ECCyto2026 in Antwerp @citologiala Sharing exper and strengthening academic ties 🌏📚🔬@milyabadli @Zoroquiainp @FridaRosenblum @MauroSaieg @MerceJorda1 @CeciliaEGimene1 @CDinares @SECitologia @MozeticV @CytologyEFCS @EfcsYoung #cytology
Milagros Abad-Licham@milyabadliSep 27
La Sociedad Latinoamericana de Citopatologia SLAC estará presente en el Congreso de la Federación Europea de Sociedades Citología Un súper equipo listo para compartir nuestras experiencias Seguimos tendiendo puentes y cruzando fronteras 🫶🏻💙😍🌎
9
22
586
Mark CC Chen, M.D. FIAC retweeted
Gloria Sura, MD@Gloria_SuraMDSep 26
Pelvic washing containing a metastatic high grade gynecologic malignancy. What cytologic preparation was used? Answer: buff.ly/3MZzIdG #PathTwitter #CytoPath #Cytology #PathArt #Pathology
6
11
1
52
3,289
Mark CC Chen, M.D. FIAC retweeted
Cioly Rivero C.
@CiolyRiveroCSep 20
Replying to @PapSociety
@PapSociety Companion Meeting #ECCyto2026 Like a Box of Chocolates: Navigating Surprises in Cytology 🍫 Chairs: @DianaEstherossi @aakasharmand 🧩 Build your diagnostic strategy 🧠 🔬 Take home tools for your everyday practice 👀 #Cytology #Cytopath @PoonamVohra3
Papanicolaou Society@PapSocietySep 20
Ready to unwrap some diagnostic surprises in cytology? Join us at the @PapSociety Companion Meeting at the 46th European Congress of Cytology in Antwerp! @PoonamVohra3 @DianaEstherossi @aakasharmand @AzizaNassar2 @mdlozanoe #ECCyto2026
10
14
747
Mark CC Chen, M.D. FIAC retweeted
Tania Labiano@tlabianoSep 22
🧠💧Cerebrospinal fluid #CSF #cytology 🔬Large cells w/ pleomorphic population of lymphoid cells with irregular nuclear contours. 📋✍🏼Patient has history of Diffuse large B-cell lymphoma. #giemsa #cytopath
2
23
1
61
2,116
Mark CC Chen, M.D. FIAC retweeted
International Academy Cytology@IACytologySep 21
#IACwebinar Join us this Friday, 25 September 2026 for: “Pancreatic #Cytopathology: New WHO Classification — An Update” 🎙️ Asif Loya, MD 🕑 2:00 PM CEST | 5:00 PM PKT 🔒 IAC members only — pre-registration required. #Pancreas #WHOClassification #Pathology #EUSFNAC
5
2
15
1,348
Mark CC Chen, M.D. FIAC retweeted
Cancer Cytopathology@CancerCytopathSep 21
Neutrophil-calibrated atypical squamous cells in ThinPrep urine cytology for detecting squamous differentiation in urothelial carcinoma acsjournals.onlinelibrary.wi… #CytoPath
10
1
30
1,094
Mark CC Chen, M.D. FIAC retweeted
Cancer Cytopathology@CancerCytopathSep 17
🔬 Free access | Diagnostic challenges in urinary cytology: Practical insights from The Paris System for Reporting Urinary Cytology acsjournals.onlinelibrary.wi… #CytoPath #ParisSystem @cjvand
14
1
37
3,336
Mark CC Chen, M.D. FIAC retweeted
nature
@NatureSep 7
Nature review: Molecular mechanisms and pathogenesis of MASH go.nature.com/4i5T1V3

Molecular mechanisms and pathogenesis of MASH

Nature - This Review highlights the state of the art of molecular and cellular mechanisms underlying MASH pathogenesis and its transition to hepatocellular carcinoma.

nature.com
2
124
4
498
80,315
Mark CC Chen, M.D. FIAC retweeted
David Kalfert@DavidKalfertSep 8
New publication in Cancer Cytopathology! 🎉🇫🇮🇨🇿 Our Finnish–Czech collaboration on rare primary pulmonary salivary gland-type tumors: overall cytohistologic concordance 48.1%, with FNA performing best (75%). Many thanks to Henri Lagerstam & Ivana Kholová doi.org/10.1002/cncy.70153 – at Horoměřice, Česká republika

Primary pulmonary salivary gland‐type tumors in cytopathology practice: A systematic review and...

This systematic review identified 49 studies on the cytologic diagnosis of primary pulmonary salivary gland-type tumors involving 106 patients. Among cytologic sampling methods, fine-needle aspirat...

acsjournals.onlinelibrary.wiley.com
2
1
7
1,144
Mark CC Chen, M.D. FIAC retweeted
Dvir Aran
@dvir_aSep 1
Our paper is out in @Cancer_Cell! We started this project almost 5 years ago with the idea that to understand why some cancer patients respond to immunotherapy and others do not, we may need to look beyond the tumor before treatment. Immunotherapy is not just a test of a pre-existing state; it is a perturbation. It changes the tumor immune microenvironment. So the question became: can the direction of that change explain response? authors.elsevier.com/a/1niWC…
11
99
6
417
24,319
Mark CC Chen, M.D. FIAC retweeted
Waggoner Lab@LabWaggonerAug 31
Review: Decoding T cell exhaustion in the tumour microenvironment nature.com/articles/s12276-0…
1
34
155
7,762
Mark CC Chen, M.D. FIAC retweeted
Cancer Cytopathology@CancerCytopathSep 1
📢 Beyond the adult standard: Tailoring the WHO Reporting System for Lymph Node Cytopathology to pediatric diagnostics and management acsjournals.onlinelibrary.wi… #CytoPath CC: @IvanaKholova
12
17
1,030
Mark CC Chen, M.D. FIAC retweeted
Cancer Cytopathology@CancerCytopathAug 28
#OpenAccess | Malignant effusions secondary to metastatic thyroid carcinomas: A review of 15 cases. Ancillary testing is extremely helpful in arriving at the correct diagnosis. acsjournals.onlinelibrary.wi… #CytoPath CC: @Sinchita_Roy
19
60
1,369
Mark CC Chen, M.D. FIAC retweeted
Syed A. Ahmad@SyedAAhmad5Aug 26
Biomarker-Driven Management of Nonmetastatic GEJ Adenocarcinoma @annsurgoncol link.springer.com/article/10…

Biomarker-Driven Management of Nonmetastatic GEJ Adenocarcinoma

Annals of Surgical Oncology - Advances in understanding the molecular landscape of gastroesophageal junction (GEJ) adenocarcinoma underscore the need for biomarker-driven treatment approaches. The...

link.springer.com
10
33
3,486
Mark CC Chen, M.D. FIAC retweeted
Cytopathology@CytopathologyJAug 25
🤔 Once in a career, you may encounter a pleural effusion case like this. When that moment comes, you'll be glad you've seen it before in the literature. #Cytopath #CytoJ ⬇️ doi.org/10.1111/cyt.70108

Unique Presentation of Metastatic Malignant Germ Cell Tumour Diagnosed on Pleural Effusion Cytology

Click on the article title to read more.

onlinelibrary.wiley.com
4
7
388
Mark CC Chen, M.D. FIAC retweeted
Cancer Cytopathology@CancerCytopathAug 26
#OpenAccess! Scrape cytology showed significantly higher diagnostic performance than imprint cytology, particularly after patients received neoadjuvant therapy. acsjournals.onlinelibrary.wi… #CytoPath @glinglerimek
2
7
1
13
1,730
Mark CC Chen, M.D. FIAC retweeted
Lola Lozano@mdlozanoeAug 19
Signet-ring cell gastric carcinoma in peritoneal fluid. In effusions, malignant cells may change their morphology to fool us -😎🧐🕵️‍♀️- but not this time! Bottom right: CDX2 nuclear positivity (smear) @IACytology @CytologyEFCS @cytopathology @SEAP_IAP
1
18
1
60
1,950
Mark CC Chen, M.D. FIAC retweeted
NEJM
@NEJMAug 19
A new review summarizes the pathogenesis and treatment of myeloproliferative neoplasms, highlighting the role of driver mutations, inflammation, and emerging targeted therapies that may achieve durable disease modification. Read the Review Article “Myeloproliferative Neoplasms” by Isabelle Plo, PhD, and William Vainchenker, MD, PhD: nej.md/4wD0AWG
An illustrated diagram from the Review Article "Myeloproliferative Neoplasms" that shows the main structures and functions of the myeloproliferative neoplasm driver mutations. Panel A shows a schematic representation of Janus kinase 2 (JAK2) in its inactive state on the thrombopoietin receptor (MPL) and in the active conformation induced by the MPL mutations or calreticulin (CALR) mutations. Panel B shows the mechanisms of oncogenic signaling activation. Mutant CALR binds to MPL monomers in the endoplasmic reticulum and travels through the canonical secretory pathway to the cell surface.

ALT An illustrated diagram from the Review Article "Myeloproliferative Neoplasms" that shows the main structures and functions of the myeloproliferative neoplasm driver mutations. Panel A shows a schematic representation of Janus kinase 2 (JAK2) in its inactive state on the thrombopoietin receptor (MPL) and in the active conformation induced by the MPL mutations or calreticulin (CALR) mutations. Panel B shows the mechanisms of oncogenic signaling activation. Mutant CALR binds to MPL monomers in the endoplasmic reticulum and travels through the canonical secretory pathway to the cell surface.

3
139
8
404
38,917
Mark CC Chen, M.D. FIAC retweeted
Syed Z. Ali
@sza_jhcytoAug 19
Textbook cytomorphology of Hepatocellular Carcinoma, Fibrolamellar type in a teenage boy, with malignant cells presenting a sharp contrast with the trapped biliary epithelium. (Liver, FNA)
4
30
108
2,784
Load more